Maximum quantity allowed is 999
请选择数量
CAS RN: 82956-11-4 | 产品编码: N0959
Nafamostat Mesylate
×
![]()
×
| 规格 | 单价 | 同一天 | 2-3个工作日 | 数量 |
|---|---|---|---|---|
| 20MG |
S$58.50
|
≥40 | ≥60 |
|
| 100MG |
S$202.50
|
≥40 | ≥100 |
|
补充产品信息:
This product is a sample for RUO (research use only). Do not use this product for any purpose other than testing and research.
技术规格
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 95.0 % |
物性（参考值）
| 熔点 | 258 °C |
| 水溶性 | 可溶 |
| 溶解性（不溶于） | 乙醚, 丙酮 |
GHS
相关法规
| RTECS# | DG2736000 |
运输信息
| HS编码* | 2925.29-000 |
应用
セリンプロテアーゼ阻害剤，ナファモスタットメシル酸塩
Nafamostat mesilate was first reported by Fujii and Hitomi in 1981 as a synthetic serine protease inhibitor. This compound inhibits various serine protease generated during the coagulation cascade and the inflammatory process. Nafamostat mesilate has been commonly used as an anticoagulant and reported as a drug for the treatments of DIC (disseminated intravascular coagulation) and acute pancreatitis and as an anticoagulant in extracorporeal circulation. (The product is for research purpose only.)
References
- New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin.
- Pharmacological studies of FUT-175, nafamstat mesylate. I. Inhibition of protease activity in in vitro and in vivo experiments
- Nafamostat mesilate (a review)
- Potent pruritogenic action of tryptase mediated by PAR-2 receptor and its involvement in anti-pruritic effect of nafamostat mesilate in mice
- Involvement of human blood arylesterases and liver microsomal carboxylesterases in nafamostat hydrolysis
参考文献
产品文档 (部分产品的分析图谱无法提供，敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助，请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注：该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉，您搜索的分析图谱无法提供。